Trade Summary

4 days ago, Heggie Theresa, serving as Dir at Biocryst Pharmaceuticals Inc (BCRX), sold 49,933 shares at $10.11 per share, for a total transaction value of $504,823.00. Following this transaction, Heggie Theresa now holds 65,352 shares of BCRX.

This sale represents a 43.00% decrease in Heggie Theresa's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 20, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 24, 2026, 4 days after the trade was made.

Biocryst Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.